Sarcoidosis 和恶性疾病之间的关联:一个全面的基于人口的队列研究
Yonatan Shneor Patt1,2, Niv Ben-Shabat1,2, Kassem Sharif1,2,3
1Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel.
Journal of clinical medicine
|December 17, 2024
概括
这项研究发现,肉病患者患血癌和固体癌症的风险更高. 癌症风险的增加在 Sarcoidosis 诊断后不久和很长时间后都很明显.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 石病是一种多系统颗粒性疾病,与癌症的相关性尚不清楚.
- 之前的研究还没有澄清了与沙尔科病的时间关系或特定癌症的联系.
研究的目的:
- 为了调查沙尔科毒症和恶性瘤之间的关联.
- 分析沙尔科毒症和癌症诊断之间的不同时间间隔,以了解它们之间的关系.
主要方法:
- 这是一项对近2.4万名沙尔科毒症患者和匹配对照 (2000-2015年) 的回顾性队列研究.
- 针对不同时间段的恶性瘤发病率的比较:总体上,在1年内,以及在1年后的沙尔科毒症诊断.
- 后勤回归模型用于估计赔率比率,调整社会人口统计学和临床变量.
主要成果:
- 麻症患者的恶性瘤患病率明显高 (19.5%) 与对照组 (13.6%) 相比.
- 对于血液学 (OR:2.94) 和固体恶性瘤 (OR:1.41) 发现了显著的关联.
- 观察到的最强的关联是淋巴瘤 (OR: 14.88),特别是在被诊断为沙丘病的一年内;对于其他癌症来说,长期持续存在高概率.
结论:
- 证实了沙尔科毒症与血液和固体恶性瘤之间存在显著的短期和长期关联.
- 强调需要加强对类菌病患者关于癌症风险的临床警.
- 建议进一步研究共享的遗传和环境机制,这些共同的遗传和环境机制是沙尔科毒症与癌症关系的基础.
相关概念视频
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:59Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
01:25Statistical Methods for Analyzing Epidemiological Data
299
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
299
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328